Scarica l'app Stockscreener
9.91
2.80%
0.27
Dopo l'orario di chiusura:
9.80
-0.11
-1.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.64
Aprire:
$9.63
Volume 24 ore:
390.09K
Relative Volume:
0.34
Capitalizzazione di mercato:
$748.73M
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-4.0449
EPS:
-2.45
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
+15.50%
1M Prestazione:
+49.13%
6M Prestazione:
+37.83%
1 anno Prestazione:
+12.10%
Intervallo 1D:
$9.6289
$9.925
Intervallo di 1 settimana:
$8.43
$10.24
Portata 52W:
$4.70
$10.44
Mind Medicine Inc Stock (MNMD) Company Profile
Nome
Mind Medicine Inc
Settore
Industria
Telefono
212-220-6633
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Confronta MNMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
9.91 | 728.33M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Evercore ISI | Outperform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-10-14 | Ripresa | Leerink Partners | Outperform |
| 2024-07-24 | Iniziato | ROTH MKM | Buy |
| 2024-05-29 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-15 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | Canaccord Genuity | Buy |
| 2022-12-09 | Ripresa | ROTH Capital | Buy |
| 2022-11-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-26 | Iniziato | Oppenheimer | Outperform |
| 2022-08-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Iniziato | ROTH Capital | Buy |
| 2021-06-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Mind Medicine Inc Borsa (MNMD) Ultime notizie
What analysts say about Mind Medicine (MindMed) Inc. stockExplosive capital appreciation - jammulinksnews.com
Mind Medicine (MindMed) Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com
All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - Yahoo Finance
Is Mind Medicine (MindMed) Inc. a good long term investmentTriple returns potential - jammulinksnews.com
Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq
What risks could impact Mind Medicine (MindMed) Inc. stock performanceFree Stock Market Beginners Guide - beatles.ru
(MNMD) Trading Signals - news.stocktradersdaily.com
What drives Mind Medicine (MindMed) Inc. stock priceLightning-fast capital gains - jammulinksnews.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
Mind Medicine stock rises as lawmakers discuss psychedelic therapy for veterans - Investing.com Canada
MindMed Announces New Employee Inducement Grants - Business Wire
Evercore ISI Sticks to Its Buy Rating for Mind Medicine (MNMD) - The Globe and Mail
Mind Medicine Inc.(NasdaqGS: MNMD) added to Russell 3000E Value Index - MarketScreener
Mind Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Psychedelic medicine stocks fall following Compass depression asset data (ATAI:NASDAQ) - Seeking Alpha
(MNMD) Trading Report - news.stocktradersdaily.com
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com South Africa
Mind Medicine at H.C. Wainwright: Strategic Advances in Neuropsychiatry By Investing.com - Investing.com Canada
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times
Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq
Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan
Mind Medicine Shareholders Approve Key Proposals at Annual Meeting - TipRanks
Analysts Offer Predictions for MNMD FY2026 Earnings - Defense World
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Two Sigma Advisers LP Buys 5,400 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Ameriprise Financial Inc. Takes Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
(MNMD) Investment Report - news.stocktradersdaily.com
Millennium Management LLC Increases Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances - Investing.com Australia
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances By Investing.com - Investing.com UK
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Two Sigma Investments LP - Defense World
Why Mind Medicine Gave Investors a Powerful Buzz in May - AOL.com
Bank of America Corp DE Reduces Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Why is Mind Medicine (MNMD) Stock Moving Today? - GuruFocus
Why Mind Medicine Gave Investors A Powerful Buzz In May - Barchart.com
Nuveen Asset Management LLC Acquires 8,856 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Mind Medicine Inc Azioni (MNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):